Showing results (321-330 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|December 3, 2025
Motivators and barriers affecting decisions to participate in sickle cell disease clinical trials in the global Learning and Insights into Sickle Cell Trial Experiences (LISTEN) Survey: global and regional findingsJohnny Mahlangu, Raffaella Colombatti, John James, et al.
The Lancet. Haematology|December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 studyMichael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
The Lancet. Haematology|February 5, 2025
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNetVincent Ribrag, Dominique Bron, Grzegorz Rymkiewicz, et al.
The Lancet. Haematology|December 9, 2024
Air pollution and venous thromboembolism: current knowledge and future perspectivesDawn Swan, Robert Turner, Massimo Franchini, et al.
The Lancet. Haematology|December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working GroupNicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.
The Lancet. Haematology|December 22, 2023
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort studyCatherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
The Lancet. Haematology|December 22, 2023
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 studyGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
The Lancet. Haematology|November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approachPeter Dreger, Paolo Corradini, John G Gribben, et al.
The Lancet. Haematology|November 29, 2023
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trialIsabelle M C Ree, Masja de Haas, Nan van Geloven, et al.
The Lancet. Haematology|February 8, 2024
Diagnosis and management of pyruvate kinase deficiency: international expert guidelinesHanny Al-Samkari, Nadine Shehata, Kelly Lang-Robertson, et al.
Pageof 73